POINT Biopharma Global In...

NASDAQ: PNT · Real-Time Price · USD
12.50
0.02 (0.16%)
At close: Dec 26, 2023, 10:00 PM

POINT Biopharma Global Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
98.29M -45.9M
Depreciation & Amortization
1.4M 11.84K
Stock-Based Compensation
3.55M 2.3M
Other Working Capital
76.03M 846.16K
Other Non-Cash Items
-1.95M n/a
Deferred Income Tax
1.39M 65.59K
Change in Working Capital
80.85M -1.18M
Operating Cash Flow
183.52M -44.7M
Capital Expenditures
-12.77M -8.8M
Cash Acquisitions
n/a n/a
Purchase of Investments
-253.5M n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
n/a n/a
Investing Cash Flow
-266.26M -8.8M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
130.36M 281.77M
Financial Cash Flow
130.36M 281.77M
Net Cash Flow
47.61M 228.27M
Free Cash Flow
170.75M -53.5M